ETF overview
Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF is an exchange traded fund launched by Direxion Investments. It is managed by Rafferty Asset Management, LLC. It invests in public equity markets of the United States. It invests directly, through derivatives and through other funds in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. It uses derivatives such as futures, swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track 3x the daily performance of the S&P Biotechnology Select Industry Index. Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF was formed on May 28, 2015 and is domiciled in the United States.
Fund facts
- Leverage
- 3x daily
- Expense ratio
- 0.96%
- Fund assets
- 642.71M USD (all share classes)
- Issuer
- Direxion
- Inception date
- May 28, 2015
- Number of holdings
- 171
Holdings (171)
| Name | Ticker | Exposure |
|---|---|---|
| SPSIBI SWAP ASSET LEG (SPSIBIUBL) | 52.46% | |
| SPSIBI SWAP ASSET LEG (SPSIBIMLL) | 47.78% | |
| SPSIBI SWAP ASSET LEG (SPSIBICTL) | 43.29% | |
| SPSIBI SWAP ASSET LEG (SPSIBIBCL) | 37.94% | |
| SPSIBI SWAP ASSET LEG (SPSIBIJPL) | 32.16% | |
| GOLDMAN FINL SQ TRSRY INST 506 | 15.71% | |
| SPSIBI SWAP ASSET LEG (SPSIBIBPL) | 10.19% | |
| SPSIBI SWAP ASSET LEG (SPSIBIGSL) | 2.83% | |
| MODERNA INC | MRNA | 1.93% |
| NATERA INC | NTRA | 1.36% |
| and 158 more | ||
This is a leveraged or inverse fund. Exposure is each position's value as a share of the fund's net assets, so swaps and futures can take it above 100% or below 0%. Cash held as collateral is not listed.
Historical returns do not guarantee future returns. This is not investment advice.
Direxion Daily S&P Biotech Bull 3X Shares (LABU)
- Leverage
- 3x daily
- Expense ratio
- 0.96%
- Fund assets
- 642.71M USD (all share classes)
- Issuer
- Direxion
- Inception date
- May 28, 2015
- Number of holdings
- 171
| Name | Ticker | Exposure |
|---|---|---|
| SPSIBI SWAP ASSET LEG (SPSIBIUBL) | 52.46% | |
| SPSIBI SWAP ASSET LEG (SPSIBIMLL) | 47.78% | |
| SPSIBI SWAP ASSET LEG (SPSIBICTL) | 43.29% | |
| SPSIBI SWAP ASSET LEG (SPSIBIBCL) | 37.94% | |
| SPSIBI SWAP ASSET LEG (SPSIBIJPL) | 32.16% | |
| GOLDMAN FINL SQ TRSRY INST 506 | 15.71% | |
| SPSIBI SWAP ASSET LEG (SPSIBIBPL) | 10.19% | |
| SPSIBI SWAP ASSET LEG (SPSIBIGSL) | 2.83% | |
| MODERNA INC | MRNA | 1.93% |
| NATERA INC | NTRA | 1.36% |
| and 158 more | ||
This is a leveraged or inverse fund. Exposure is each position's value as a share of the fund's net assets, so swaps and futures can take it above 100% or below 0%. Cash held as collateral is not listed.
Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF is an exchange traded fund launched by Direxion Investments. It is managed by Rafferty Asset Management, LLC. It invests in public equity markets of the United States. It invests directly, through derivatives and through other funds in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. It uses derivatives such as futures, swaps to create its portfolio. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track 3x the daily performance of the S&P Biotechnology Select Industry Index. Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF was formed on May 28, 2015 and is domiciled in the United States.
Unlock all ETF data
Sign up for FreeUnlock all ETF data
Sign up for Free